Swallowable drug delivery device and method of delivery
View Patent ↗Embodiments of the invention provide swallowable devices, preparations and methods for delivering drugs and other therapeutic agents within the GI tract. Some embodiments provide a swallowable device such as a capsule for delivering drugs into the intestinal wall or other GI lumen. The device comprises a capsule sized to be swallowed and pass through the intestinal tract. The capsule can include at least one guide tube, one or more tissue penetrating members positioned in the guide tube, a delivery member, an actuating mechanism and a release element. The release element degrades upon exposure to various conditions in the intestine so as to release and actuate the actuating mechanism. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
1. A method for delivering a therapeutic agent into a wall of the small intestine of a patient, the method comprising: swallowing a drug delivery device comprising a capsule, an expandable member and a therapeutic agent preparation shaped as a solid tissue penetrating member, the tissue penetrating member coupled to the expandable member by an advancement member that advances the tissue penetrating member into the wall of the small intestine upon expansion of the expandable member, an end of the advancement member detachably engaging a non-tissue penetrating end of the tissue penetrating member, wherein the end of the advancement member engaging the tissue penetrating member has a larger horizontal surface area than the non-tissue penetrating end of the tissue penetrating member; and
expanding the expandable member responsive to a condition in the small intestine to apply a force to a solid surface of the tissue penetrating member using the advancement member so as to insert the tissue penetrating member into the wall of the small intestine where it remains and degrades to release the therapeutic agent into the patient's blood stream.
2. The method of claim 1 , wherein the condition is a selected pH.
3. The method of claim 2 , wherein the pH is above about 7.1.
4. The method of claim 1 , wherein the therapeutic agent comprises a therapeutically effective dose of insulin for treatment of diabetes or a glucose regulation disorder; the method further comprising: using the dose of delivered insulin to control a blood glucose level of the patient without injecting insulin into the patient.
5. The method of claim 1 , wherein the therapeutic agent comprises a therapeutically effective dose of an incretin for treatment of diabetes or a glucose regulation disorder; the method further comprising: using the dose of delivered incretin to control a blood glucose level of the patient without injecting insulin into the patient.
6. The method of claim 1 , wherein the therapeutic agent comprises a therapeutically effective dose of an incretin and a therapeutically effective dose of a biguanide for treatment of diabetes or a glucose regulation disorder; the method further comprising: using the doses of delivered incretin and biguanide to control a blood glucose level of the patient.
7. The method of claim 6 , wherein the incretin comprises exenatide and the biguanide comprises metformin.
8. The method of claim 7 , wherein the dose of the incretin is matched to the dose of biguanide to produce an improved level of blood glucose control for an extended period.
9. The method of claim 8 , wherein the extended period is up to about a day.
10. The method of claim 1 , wherein the expandable member comprises an expandable balloon.
11. A method for delivering a therapeutic agent into a wall of the small intestine of a patient, the method comprising: swallowing a drug delivery device comprising a capsule, an expandable member and a therapeutic agent preparation shaped as a tissue penetrating member having a shaft and a tissue penetrating end, the tissue penetrating member coupled to the expandable member by an advancement member that advances the tissue penetrating member into the wall of the small intestine upon expansion of the expandable member, an end of the advancement member detachably engaging a non-tissue penetrating end of the tissue penetrating member, wherein the end of the advancement member engaging the tissue penetrating member has a larger horizontal surface area than the non-tissue penetrating end of the tissue penetrating member; and
expanding the expandable member responsive to a condition in the small intestine to apply a force to a surface of the tissue penetrating member using the advancement member so as to insert the tissue penetrating member into the wall of the small intestine where it remains and degrades to release the therapeutic agent into the patient's blood stream.
12. The method of claim 11 , wherein the condition is a selected pH.
13. The method of claim 12 , wherein the pH is above about 7.1.
14. The method of claim 11 , wherein the therapeutic agent comprises a therapeutically effective dose of insulin for treatment of diabetes or a glucose regulation disorder; the method further comprising: using the dose of delivered insulin to control a blood glucose level of the patient without injecting insulin into the patient.
15. The method of claim 11 , wherein the therapeutic agent comprises a therapeutically effective dose of an incretin for treatment of diabetes or a glucose regulation disorder; the method further comprising: using the dose of delivered incretin to control a blood glucose level of the patient without injecting insulin into the patient.
16. The method of claim 11 , wherein the expandable member comprises an expandable balloon.
17. A method for delivering a therapeutic agent into a wall of the small intestine of a patient, the method comprising:
swallowing a drug delivery device comprising a capsule, an expandable member and a therapeutic agent preparation shaped as a tissue penetrating member; the expandable member disposed in the capsule; and
expanding the expandable member responsive to a condition in the small intestine to apply a force to a solid surface of the therapeutic agent preparation so as to insert the tissue penetrating member into the wall of the small intestine where it remains and degrades to release the therapeutic agent into the patient's blood stream, and wherein when the expandable member expands it breaks apart at least a portion of the capsule.
18. The method of claim 17 , wherein the expandable member is a balloon.